Ketoconazole, an Antifungal Agent, Protects Against Adiposity Induced by a Cafeteria Diet

Abstract

Ketoconazole, an anti-glucocorticoid agent, is widely used in humans as an antifungal agent. It inhibits ergosterol synthesis and reduces cortisol levels in the treatment of Cushing’s Syndrome. The aim of this work was to study the drug’s preventive potential against adiposity induced by a high-fat cafeteria diet in rats. Female Wistar rats were fed on standard pelleted diet or cafeteria diet during 42 days in the presence or absence of an oral treatment with ketoconazole (24 mg/kg of body weight). The cafeteria diet increased energy intake and body weight. In addition, this high-fat diet increased body-fat weight and adipose tissue depots analyzed. Interestingly, ketoconazole was able to protect against increased total body fat and adipose depot enlargement induced after cafeteria-diet feeding. Moreover, ex vivo isoproterenol-induced lipolysis was reduced in adipocytes from cafeteria-fed animals; this decrease was reverted by treatment with ketoconazole. Thus, ketoconazole was able to protect against adiposity induced by a cafeteria diet, revealing an interaction between fat intake and glucocorticoids on adipose deposition.

Key words

High fat diet · Glucocorticoids · Lipolysis · Adipocytes · Obesity · Rat

References

• 1 Tataranni P A. Treatment of obesity: should we target the individual or society?.  Curr Pharm Des. 2003;  9 (15) 1151-1163
• 2 Martinez J A. Body-weight regulation: causes of obesity.  Proc Nutr Soc. 2000;  59 (3) 337-345
• 3 Marti A, Vaquerizo J, Zulet M A, Moreno-Aliaga M J, Martinez J A. Down-regulation of heart HFABP and UCP2 gene expression in diet-induced (cafeteria) obese rats.  J Physiol Biochem. 2002;  58 (2) 69-74
• 4 Gianotti M, Roca P, Palou A. Body weight and tissue composition in rats made obese by a cafeteria diet. Effect of 24 hours starvation.  Horm Metab Res. 1988;  20 (4) 208-212
• 5 Berraondo B, Martinez J A. Free fatty acids are involved in the inverse relationship between hormone-sensitive lipase (HSL) activity and expression in adipose tissue after high-fat feeding or beta3-adrenergic stimulation.  Obes Res. 2000;  8 (3) 255-261
• 6 Udden J, Eriksson P, Hoffstedt J. Glucocorticoid-regulated adipose tissue secretion of PAI-1, but not IL-6, TNFalpha or leptin in vivo.  Horm Metab Res. 2002;  34 (11 - 12) 698-702
• 7 Masuzaki H, Paterson J, Shinyama H, Morton N M, Mullins J J, Seckl J R, Flier J S. A transgenic model of visceral obesity and the metabolic syndrome.  Science. 2001;  294 (5549) 2166-2170
• 8 Tomlinson J W, Stewart P M. The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.  Horm Metab Res. 2002;  34 (11 - 12) 746-751
• 9 Mantha L, Palacios E, Deshaies Y. Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity.  Am J Physiol. 1999;  277 (2 Pt 2) R455-464
• 10 Saito M, Bray G A. Adrenalectomy and food restriction in the genetically obese (ob/ob) mouse.  Am J Physiol. 1984;  246 (1 Pt 2) R20-25
• 11 Bray G A, Stern J S, Castonguay T W. Effect of adrenalectomy and high-fat diet on the fatty Zucker rat.  Am J Physiol. 1992;  262 (1 Pt 1) E32-39
• 12 Dutta D, Sharma R. Regulation of hepatic glucocorticoid receptors in mice during dietary restriction.  Horm Metab Res. 2003;  35 (7) 415-420
• 13 Hansen P A, Han D H, Nolte L A, Chen M, Holloszy J O. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet.  Am J Physiol. 1997;  273 (5 Pt 2) R1704-1708
• 14 Langley S C, York D A. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats.  Am J Physiol. 1990;  259 (3 Pt 2) R539-544
• 15 Restrepo A, Stevens D A, Utz J P. First International Symposium on Ketoconazole.  Rev Infect Dis. 1980;  2 (4) 519-562
• 16 Como J A, Dismukes W E. Oral azole drugs as systemic antifungal therapy.  N Engl J Med. 1994;  330 (4) 263-272
• 17 Cummings A M, Hedge J L, Laskey J. Ketoconazole impairs early pregnancy and the decidual cell response via alterations in ovarian function.  Fundam Appl Toxicol. 1997;  40 (2) 238-246
• 18 Bhasin S, Sikka S, Fielder T, Sod-Moriah U, Levine H B, Swerdloff R S, Rajfer J. Hormonal effects of ketoconazole in vivo in the male rat: mechanism of action.  Endocrinology. 1986;  118 (3) 1229-1232
• 19 Cohen H, Benjamin J, Kaplan Z, Kotler M. Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model.  Eur Neuropsychopharmacol. 2000;  10 (6) 429-435
• 20 Loh K C, Gupta R, Shlossberg A H. Spontaneous remission of ectopic Cushing’s syndrome due to pheochromocytoma: a case report.  Eur J Endocrinol. 1996;  135 (4) 440-443
• 21 Nieman L K. Medical therapy of Cushing’s disease.  Pituitary. 2002;  5(2) 77-82
• 22 Margareto J, Aguado M, Oses-Prieto J A, Rivero I, Monge A, Aldana I, Marti A, Martinez J A. A new NPY-antagonist strongly stimulates apoptosis and lipolysis on white adipocytes in an obesity model.  Life Sci. 2000;  68 (1) 99-107
• 23 Berraondo B, Marti A, Duncan J S, Trayhurn P, Martinez J A. Up-regulation of muscle UCP2 gene expression by a new beta3- adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animals.  Int J Obes Relat Metab Disord. 2000;  24 (2) 156-163
• 24 Azer S A, Kukongviriyapan V, Stacey N H. Mechanism of ketoconazole-induced elevation of individual serum bile acids in the rat: relationship to the effect of ketoconazole on bile acid uptake by isolated hepatocytes.  J Pharmacol Exp Ther. 1995;  272 (3) 1231-1237
• 25 Galitzky J, Reverte M, Portillo M, Carpene C, Lafontan M, Berlan M. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.  Am J Physiol. 1993;  264 (3 Pt 1) E403-412
• 26 Dole V P, Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues.  J Biol Chem. 1960;  235 (5) 375-380
• 27 Collins S, Daniel K W, Rohlfs E M. Depressed expression of adipocyte beta-adrenergic receptors is a common feature of congenital and diet-induced obesity in rodents.  Int J Obes Relat Metab Disord. 1999;  23 (7) 669-677
• 28 Portillo M P, Simon E, Garcia-Calonge M A, Del Barrio A S. Effect of high-fat diet on lypolisis in isolated adipocytes from visceral and subcutaneous WAT.  Eur J Nutr. 1999;  38 (4) 177-182
• 29 Ashby J, Lefevre P A. The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, oestrogens and metabolic modulators.  J Appl Toxicol. 2000;  20 (1) 35-47
• 30 O’Connor J C, Cook J C, Slone T W, Makovec G T, Frame S R, Davis L G. An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs).  Toxicol Sci. 1998;  46 (1) 45-60
• 31 Thomson R G, Rawlins M D, James O F, Wood P, Williams F M. The acute and subchronic effects of ketoconazole on hepatic microsomal monooxygenases in the rat.  Biochem Pharmacol. 1988;  37 (20) 3975-3980
• 32 Strack A M, Bradbury M J, Dallman M F. Corticosterone decreases nonshivering thermogenesis and increases lipid storage in brown adipose tissue.  Am J Physiol. 1995;  268 (1 Pt 2) R183-191
• 33 Carroll M E, Campbell U C, Heideman P. Ketoconazole suppresses food restriction-induced increases in heroin self-administration in rats: sex differences.  Exp Clin Psychopharmacol. 2001;  9 (3) 307-316
• 34 O’Connor J C, Frame S R, Ladics G S. Evaluation of a 15-day screening assay using intact male rats for identifying steroid biosynthesis inhibitors and thyroid modulators.  Toxicol Sci. 2002;  69 (1) 79-91
• 35 Okada S, York D A, Bray G A. Mifepristone (RU 486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity.  Am J Physiol. 1992;  262 (6 Pt 2) R1106-1110
• 36 Michel C, Levin B E, Dunn-Meynell A A. Stress facilitates body weight gain in genetically predisposed rats on medium-fat diet.  Am J Physiol Regul Integr Comp Physiol. 2003;  285 (4) R791-799
• 37 Tannenbaum B M, Brindley D N, Tannenbaum G S, Dallman M F, McArthur M D, Meaney M J. High-fat feeding alters both basal and stress-induced hypothalamic-pituitary-adrenal activity in the rat.  Am J Physiol. 1997;  273 (6 Pt 1) E1168-1177
• 38 Dallman M F, Pecoraro N, Akana S F, La Fleur S E, Gomez F, Houshyar H, Bell M E, Bhatnagar S, Laugero K D, Manalo S. Chronic stress and obesity: a new view of ”comfort food”.  Proc Natl Acad Sci U S A. 2003;  100 (20) 11696-11701
• 39 Moreno-Aliaga M J, Lamas O, Marti A, Martinez J A. Effects of a beta3-adrenergic agonist on glucose uptake and leptin expression and secretion in cultured adipocytes from lean and overweight (cafeteria) rats.  Biochem Biophys Res Commun. 2002;  291 (5) 1201-1207
• 40 Owen O E, Cahill G F, Jr. Metabolic effects of exogenous glucocorticoids in fasted man.  J Clin Invest. 1973;  52 (10) 2596-2605
• 41 Reynisdottir S, Wahrenberg H, Bylin G, Arner P. Effect of glucocorticosteroid treatment on beta-adrenoceptor subtype function in adipocytes from patients with asthma.  Clin Sci (Lond). 1993;  85 (2) 237-244
• 42 Divertie G D, Jensen M D, Miles J M. Stimulation of lipolysis in humans by physiological hypercortisolemia.  Diabetes. 1991;  40 (10) 1228-1232
• 43 Horber F F, Marsh H M, Haymond M W. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans.  Diabetes. 1991;  40 (1) 141-149
• 44 Rebuffe-Scrive M, Krotkiewski M, Elfverson J, Bjorntorp P. Muscle and adipose tissue morphology and metabolism in Cushing’s syndrome.  J Clin Endocrinol Metab. 1988;  67 (6) 1122-1128
• 45 Lacasa D, Agli B, Giudicelli Y. Permissive action of glucocorticoids on catecholamine-induced lipolysis: direct ”in vitro” effects on the fat cell beta-adrenoreceptor-coupled-adenylate cyclase system.  Biochem Biophys Res Commun. 1988;  153 (2) 489-497
• 46 Ottosson M, Lonnroth P, Bjorntorp P, Eden S. Effects of cortisol and growth hormone on lipolysis in human adipose tissue.  J Clin Endocrinol Metab. 2000;  85 (2) 799-803
• 47 Pedersen S B, Borglum J D, Moller-Pedersen T, Richelsen B. Characterization of nuclear corticosteroid receptors in rat adipocytes. Regional variations and modulatory effects of hormones.  Biochim Biophys Acta. 1992;  1134 (3) 303-308
• 48 Lau D C, Roncari D A. Effects of glucocorticoid hormones on lipid-synthetic enzymes from different adipose tissue regions and from liver.  Can J Biochem Cell Biol. 1983;  61 (12) 1245-1250
• 49 Hauner H, Pfeiffer E F. Regional differences in glucocorticoid action on rat adipose tissue metabolism.  Horm Metab Res. 1989;  21 (10) 581-582
• 50 Rebuffe-Scrive M, Walsh U A, McEwen B, Rodin J. Effect of chronic stress and exogenous glucocorticoids on regional fat distribution and metabolism.  Physiol Behav. 1992;  52 (3) 583-590
• 51 Pujol E, Rodriguez-Cuenca S, Frontera M, Justo R, Llado I, Kraemer F B, Gianotti M, Roca P. Gender- and site-related effects on lipolytic capacity of rat white adipose tissue.  Cell Mol Life Sci. 2003;  60 (9) 1982-1989
• 52 Llado I, Estrany M E, Rodriguez E, Amengual B, Roca P, Palou A. Effects of cafeteria diet feeding on beta3-adrenoceptor expression and lipolytic activity in white adipose tissue of male and female rats.  Int J Obes Relat Metab Disord. 2000;  24 (11) 1396-1404
• 53 Llado I, Rodriguez-Cuenca S, Pujol E, Monjo M, Estrany M E, Roca P, Palou A. Gender effects on adrenergic receptor expression and lipolysis in white adipose tissue of rats.  Obes Res. 2002;  10 (4) 296-305
• 54 Langin D, Tavernier G, Lafontan M. Regulation of beta 3-adrenoceptor expression in white fat cells.  Fundam Clin Pharmacol. 1995;  9 (2) 97-106
• 55 Wajchenberg B L, Bosco A, Marone M M, Levin S, Rocha M, Lerario A C, Nery M, Goldman J, Liberman B. Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing’s disease.  J Clin Endocrinol Metab. 1995;  80 (9) 2791-2794
• 56 Djurhuus C B, Gravholt C H, Nielsen S, Mengel A, Christiansen J S, Schmitz O E, Moller N. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans.  Am J Physiol Endocrinol Metab. 2002;  283 (1) E172-177
• 57 Wade G N, Gray J M, Bartness T J. Gonadal influences on adiposity.  Int J Obes. 1985;  9 (Suppl 1) 83-92
• 58 Richard D, Picard F, Lemieux C, Lalonde J, Samson P, Deshaies Y. The effects of topiramate and sex hormones on energy balance of male and female rats.  Int J Obes Relat Metab Disord. 2002;  26 (3) 344-353
• 59 Marin P, Arver S. Androgens and abdominal obesity.  Baillieres Clin Endocrinol Metab. 1998;  12 (3) 441-451
• 60 Bjorntorp P. Hormonal control of regional fat distribution.  Hum Reprod. 1997;  12 (Suppl 1) 21-25
• 61 Latrille F, Charuel C, Lodola A. A comparative study of the effects of ketoconazole and fluconazole on 17-beta estradiol production by rat ovaries in vitro.  Res Commun Chem Pathol Pharmacol. 1989;  64 (1) 173-176
• 62 Deshaies Y, Dagnault A, Lalonde J, Richard D. Interaction of corticosterone and gonadal steroids on lipid deposition in the female rat.  Am J Physiol. 1997;  273 (2 Pt 1) E355-362
• 63 Calle C, Sanchez-Casas P, Simon M A, Mayor P. Binding and action of glucagon in isolated adipocytes from cortisol-treated rats.  Biochem Biophys Res Commun. 1987;  145 (1) 90-95
• 64 Calle C, Sanchez-Casas P, Carranza M C, Simon M A, Mayor P. Binding and antilipolytic action of insulin in isolated adipocytes from cortisol-treated rats.  Rev Esp Fisiol. 1988;  44 (3) 309-314
• 65 Watanabe H, Menzies J A. Depression of ovarian estradiol-17 beta following single oral dose of ketoconazole.  Res Commun Chem Pathol Pharmacol. 1985;  48 (1) 141-144
• 66 Svec F. Differences in the interaction of RU 486 and ketoconazole with the second binding site of the glucocorticoid receptor.  Endocrinology. 1988;  123 (4) 1902-1906